Try our mobile app

General information

Sector: Health Care

The company is not available at Interactive Brokers

AfroCentric Investment Corp (JSE:ACT) is a majority black-owned holding company providing services and products to the healthcare sector. The Group was founded in 2008 on the core philosophy of promoting transformation and empowerment.

What we do

Through the company's operating subsidiaries, AfroCentric increases access to sustainable, affordable and quality healthcare by providing health administration, health risk management and a range of complementary solutions across the healthcare value chain to its medical scheme clients and their members. A primary lever in the company's strategy is to reduce the cost of healthcare by eliminating inefficiency throughout the healthcare value chain.



  • Bad financial results growth rate -30.1% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (0.0%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 45.5% (LTM)
  • Share price is 1.5% higher than minimum and 55.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (3.4x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials

Share price, ZAR:  (0.0%)2.64
Share price, USD: 0.1440
Common stocks: 840 909 091

Dividend Yield:  0.0%
FCF Yield LTM: 45.5%
EV / LTM EBITDA: 3.4x
Last revenue growth (y/y):  -13.3%
Last growth of EBITDA (y/y):  -46.9%
Historical revenue growth:  +8.5%
Historical growth of EBITDA:  +0.9%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 121
Net Debt ($m): 46
EV (Enterprise Value): 167
EBITDA LTM ($m): 49
EV / LTM EBITDA: 3.4x
Price to Book: 0.65x

Revenue and EBITDA

Semi-Annual values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment ZAR per share

Multiple and potential

EV / EBITDA

Potential dynamics

TechCentral Headlines

Software developer escalates 15-year battle with Medscheme

Software developer Neil Harvey & Associates has escalated its 15-year legal battle with Medscheme over alleged copyright infringement.

2021-12-13 09:33 +02:00
by Roy Cokayne

JSE:SLM JSE:JSE JSE:MPT JSE:ACT JSE:ARH JSE:ISA

EOH unloads Denis Group for R250-million

EOH Holdings subsidiary EOH Abantu has agreed to sell its shares in Dental Information Systems (Denis Group) to AfroCentric Investment Corp for an effective R250-million.

2019-12-13 09:42 +02:00
by Duncan McLeod

JSE:JSE JSE:ACT JSE:EOH

More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data

Releases

2022-06-21
Changes to the board
2022-06-15
Finalisation of fairness opinion for the acquisition of remaining interest in Afrocentric Distribution Services
2022-06-08
ACQUISITION OF REMAINING INTEREST IN AFROCENTRIC DISTRIBUTION SERVICES
2022-05-25
Dealing by an associate
2022-05-25
Dealings by an associate
2022-05-16
Dealings by an associate
2022-04-29
Increase in shareholding
2022-04-28
Dealings in LTIP scheme
2022-04-28
Dealings in securities by an Associate of a Director:
2022-04-22
Dealings in securities by an Associate of a Director:
2022-04-14
Dealings by an associate
2022-04-08
Dealings by an associate
2022-04-05
Dealing in securities by an associate of a director
2022-03-31
Dealings by an Associate
2022-03-28
Dealings by an associate and dealing in LTIP scheme by Company Secretary
2022-03-22
Dealings relating to vesting of shares under the AfroCentric LTIP
2022-03-15
interim results for the six months ended 31 December 2021, dividend declaration and change in the role of a Director
2021-12-24
availability of B-BBEE Compliance Report and Certificate
2021-11-19
Changes to the board

SENS Announcements

2024-05-10
Dealing in securities by directors of the Company, the Company Secretary and a Director of Major Subsidiaries
2024-05-02
Dealing in securities by a Director of a Major Subsidiary
2024-03-27
Medscheme wins 17-year-old legal battle
2024-03-04
Condensed unaudited interim results for the six months ended 31 December 2023
2024-02-12
Interim results publication date
2024-02-02
Change to the board
2024-01-08
Change to company secretary
2023-12-21
Dealing in Securities by the Company Secretary and a Director of a Major Subsidiary
2023-12-18
Availability of Broad-Based Black Economic Empowerment (“B-BBEE”) Compliance Report and Certificate
2023-12-14
Change in Beneficial Interests Pursuant to Intra-Group Transaction
2023-11-10
Results of the annual general meeting
2023-10-13
Dealing in securities by the company secretary
2023-10-09
Availability of the Integrated Annual Report and Notice of AGM
2023-09-29
Dealing in securities by a director of a major subsidiary
2023-09-18
Summarised audited results for the year ended 30 June 2023
2023-09-14
Trading statement
2023-07-31
Change to company secretary
2023-07-03
changes to the board and leadership update: AfroCentric Group
2023-06-15
Changes to the board
2023-06-09
Dealing in securities by a director
2023-05-31
Change in Auditor
2023-05-29
Sanlam share consideration
2023-05-25
Sanlam partial offer to AfroCentric shareholders: cash payment applicable to fractional entitlements
2023-05-11
Dealing in securities by directors of the company, company secretary and director of a major subsidiary
2023-05-11
Dealings in Securities by Director
2023-05-08
Finalisation announcement - Sanlam partial offer to AfroCentric shareholders wholly unconditional
2023-03-16
Extension of offer closing date of Sanlam’s partial offer to Afrocentric shareholders
2023-03-13
Summarised unaudited interim results for the six months ended 31 December 2022
2023-03-13
CANCELLATION OF S472647 Summarised unaudited interim results for the six months ended 31 December 2022
2023-03-13
Summarised unaudited interim results for the six months ended 31 December 2022
2023-02-14
Sanlam partial offer to AfroCentric shareholders unconditional as to acceptances
2023-02-13
Dealings in securities by Directors and their Associates
2023-01-17
Dealing in securities by a Director of AfroCentric relating to vesting of Share Option Awards
2023-01-12
Results of the General Meeting of Afrocentric Shareholders
2022-12-22
Availability of updated B-BEE certificate
2022-12-19
Dealing in securities by a Director
2022-12-19
Dealing by a company secretary
2022-11-22
Renewal of Cautionary Announcement
2022-11-10
Results of AGM
2022-10-12
No change statement, notice of AGM and availability of B-BEE certificate
2022-09-13
Summarised audited results for the financial year ended 30 June 2022 and dividend declaration
2022-09-08
Update to schedule 13: Directors declaration
2022-06-21
Changes to the board
2022-06-15
Finalisation of fairness opinion for the acquisition of remaining interest in Afrocentric Distribution Services
2022-06-08
ACQUISITION OF REMAINING INTEREST IN AFROCENTRIC DISTRIBUTION SERVICES
2022-05-25
Dealing by an associate
2022-05-25
Dealings by an associate
2022-05-16
Dealings by an associate